FITLIFE BRANDS, INC. Recapitalization Costs
FITLIFE BRANDS, INC. (FTLF) reported Recapitalization Costs of $0 for the 9-month period ending 2016-09-30, per its 10-Q filed 2016-11-14.
Discontinued › Expense Statement › Operating Expenses
us-gaap:RecapitalizationCosts · last filed 2016-11-14
- FITLIFE BRANDS, INC. recapitalization costs for the quarter ending 2016-09-30 was $0.00.
- FITLIFE BRANDS, INC. recapitalization costs for the quarter ending 2016-06-30 was $0.00.
- FITLIFE BRANDS, INC. recapitalization costs for the quarter ending 2016-03-31 was $0.00.
- FITLIFE BRANDS, INC. recapitalization costs for the quarter ending 2015-09-30 was -$57.51K.
| Period end | Recapitalization Costs 3 month | Recapitalization Costs 6 month | Recapitalization Costs 6 month as first filed | Recapitalization Costs 9 month |
|---|---|---|---|---|
| 2016-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-14 | $0.00 derived: sum of 2 quarters · filed 2016-11-14 | $0.00 10-Q · filed 2016-11-14 | |
| 2016-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-15 | $0.00 10-Q · filed 2016-08-15 | ||
| 2016-03-31 | $0.00 10-Q · filed 2016-05-16 | |||
| 2015-09-30 | -$57.51K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-14 | -$57.51K derived: sum of 2 quarters · filed 2016-11-14 | -$57.51K 10-Q · filed 2016-11-14 | |
| 2015-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-15 | $0.00 10-Q · filed 2016-08-15 | -$30.47K 10-Q · filed 2015-08-13 | |
| 2015-03-31 | $0.00 10-Q · filed 2016-05-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MANNATECH INC (MTEX) | United States | $0.014B | |
| NATURAL ALTERNATIVES INTERNATIONAL INC (NAII) | United States | $0.011B | -1.16 |
| Synergy CHC Corp. (SNYR) | United States | $0.001B | |
| Functional Brands Inc. (MEHA) | United States | $0.001B | |
| Niagen Bioscience, Inc. (NAGE) | United States | $0.238B | 15.72 |
| USANA HEALTH SCIENCES INC (USNA) | United States | $0.264B | -17.90 |
| Canopy Growth Corp (CGC) | $0.395B | ||
| Tilray Brands, Inc. (TLRY) | United States | $0.554B | -5.97 |
| Cronos Group Inc. (CRON) | $1.223B | ||
| Definium Therapeutics, Inc. (DFTX) | United States | $4.931B | -17.87 |